Proteinase-activated receptor-4 evoked colorectal analgesia in mice: An endogenously activated feed-back loop in visceral inflammatory pain

Neurogastroenterology and Motility

Volumn 24, Issue 1, 2012, Pages

  Annahazi A ^a,b   Dabek, M ^a   Gecse, K ^b   Salvador Cartier, C ^a   Polizzi, A ^a   Rosztoczy A ^b   Roka R ^b   Theodorou, V ^a   Wittmann, T ^b   Bueno, L ^a   Eutamene, H ^a  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Proteinase activated receptor; TNBS; Visceral pain

Indexed keywords

2,4,6 TRIAMINOPYRIDINE; ALANYLTYROSYLPROLYLGLYCYLLYSYLPHENYLALANINAMIDE; AMINOPYRIDINE DERIVATIVE; HORMONE RECEPTOR BLOCKING AGENT; PEPTIDE; PROTEIN FOS; PROTEINASE ACTIVATED RECEPTOR 4; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON DILATATION; COLORECTAL DISEASE; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAPHY; FEEDBACK SYSTEM; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MOUSE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM; STATISTICAL SIGNIFICANCE; STRESS; TIGHT JUNCTION; VISCERAL PAIN;

ANIMALS; COLON; DILATATION, PATHOLOGIC; ELECTROMYOGRAPHY; FEEDBACK, PHYSIOLOGICAL; HYPERALGESIA; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, THROMBIN; RECTUM; TRINITROBENZENESULFONIC ACID; VISCERAL PAIN;

EID: 84155186461     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01805.x     Document Type: Article

References (42)

1. Hollenberg MD, Compton SJ. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002; 54: 203-17.
2. Houle S, Papez MD, Ferazzini M, Hollenberg MD, Vergnolle N. Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents. Br J Pharmacol 2005; 146: 670-8.
3. Kawabata A, Matsunami M, Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol 2008; 153(Suppl. 1): S230-40.
4. Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002; 122: 1035-47.
5. Gecse K, Roka R, Ferrier L et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008; 57: 591-9.
6. Annahazi A, Gecse K, Dabek M et al. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain 2009; 144: 209-17.
7. Dabek M, Ferrier L, Roka R et al. Luminal cathepsin g and protease-activated receptor 4. A Duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am J Pathol 2009; 175: 207-14.
8. Mule F, Pizzuti R, Capparelli A, Vergnolle N. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 2004; 53: 229-34.
9. Asfaha S, Cenac N, Houle S et al. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol 2007; 150: 176-85.
10. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007; 28: 541-50.
11. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527-30.
12. Larauche M, Gourcerol G, Million M, Adelson DW, Tache Y. Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses. Stress 2010; 13: 343-54.
13. Eutamene H, Bradesi S, Larauche M et al. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil 2010; 22: e312-84.
14. Auge C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil 2009; 21: 1189-e107.
15. Russell FA, Veldhoen VE, Tchitchkan D, McDougall JJ. Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism. J Neurophysiol 2010; 103: 155-63.
16. Karanjia R, Spreadbury I, Bautista-Cruz F, Tsang ME, Vanner S. Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol Motil 2009; 21: 1218-21.
17. Moreno JH. Blockage of gallbladder tight junction cation-selective channels by 2, 4, 6-triaminopyrimidinium (TAP). J Gen Physiol 1975; 66: 97-115.
18. Moreno JH. Blockage of cation permeability across the tight junctions of gallbladder and other leaky epithelia. Nature 1974; 251: 150-1.
19. Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain 2005; 113: 141-7.
20. Piche T, Barbara G, Aubert P et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009; 58: 196-201.
21. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 2009; 146: 41-6.
22. Rullier A, Senant N, Kisiel W et al. Expression of protease-activated receptors and tissue factor in human liver. Virchows Arch 2006; 448: 46-51.
23. Moormann C, Artuc M, Pohl E et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 2006; 126: 746-55.
24. Cenac N, Coelho AM, Nguyen C et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002; 161: 1903-15.
25. Moffatt JD, Lever R, Page CP. Effects of inhaled thrombin receptor agonists in mice. Br J Pharmacol 2004; 143: 269-75.
26. Verma-Gandhu M, Bercik P, Motomura Y et al. CD4+T-cell modulation of visceral nociception in mice. Gastroenterology 2006; 130: 1721-8.
27. Jesmin S, Gando S, Zaedi S, Sakuraya F. Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury. Inflammation 2007; 30: 14-27.
28. Scheiffele F, Fuss IJ. Induction of TNBS colitis in mice. Curr Protoc Immunol 2002; 15.19: 1-15.
29. Melgar S, Hammarstrom S, Oberg A, Danielsson A, Hammarstrom ML. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine. Scand J Immunol 2004; 60: 167-77.
30. Quock RM, Mueller JL, Vaughn LK. Strain-dependent differences in responsiveness of mice to nitrous oxide (N2O) antinociception. Brain Res 1993; 614: 52-6.
31. Traub RJ, Herdegen T, Gebhart GF. Differential expression of c-fos and c-jun in two regions of the rat spinal cord following noxious colorectal distention. Neurosci Lett 1993; 160: 121-5.
32. Christianson JA, Traub RJ, Davis BM. Differences in spinal distribution and neurochemical phenotype of colonic afferents in mouse and rat. J Comp Neurol 2006; 494: 246-59.
33. Asfaha S, Brussee V, Chapman K, Zochodne DW, Vergnolle N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 2002; 135: 1101-6.
34. Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997; 9: 271-9.
35. Santos J, Yang PC, Soderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630-6.
36. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001; 429: 161-76.
37. Sabri A, Alcott SG, Elouardighi H et al. Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J Biol Chem 2003; 278: 23944-54.
38. Raymond WW, Trivedi NN, Makarova A et al. How immune peptidases change specificity: cathepsin G gained tryptic function but lost efficiency during primate evolution. J Immunol 2010; 185: 5360-8.
39. Liao CH, Chen JJ, Lin JE et al. 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3, 7-dimethoxy-4H-chromen-4-one (MSF-2) suppresses fMLP-mediated respiratory burst in human neutrophils by inhibiting phosphatidylinositol 3-kinase activity. J Cell Physiol 2011; 226: 1519-30.
40. Martin L, Augé C, Boué J et al. Thrombin receptor: an endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain 2009; 146: 121-9.
41. Ramachandran R, Sadofsky LR, Xiao Y et al. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4. Am J Physiol 2007; 292: L788-98.
42. D'Andrea MR, Saban MR, Nguyen NB, Andrade-Gordon P, Saban R. Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder. Am J Pathol 2003; 162: 907-23.